Stimulation of insulin signaling pathways through the solute carrier family 2 (facilitated glucose transporter) members 4 and 2 was the mechanism underlying the beneficial effects of EEI on obesity-induced insulin resistance. The gene discussed is INS; the disease is obesity disorder.